Mark N.K. Bagnall
2008
In 2008, Mark N.K. Bagnall earned a total compensation of $393.9K as Former Chief Financial Officer at Mast Therapeutics.
Compensation breakdown
| Option Awards | $37,599 |
|---|---|
| Salary | $258,462 |
| Other | $97,791 |
| Total | $393,852 |
Bagnall received $258.5K in salary, accounting for 66% of the total pay in 2008.
Bagnall also received $37.6K in option awards and $97.8K in other compensation.
Rankings
In 2008, Mark N.K. Bagnall's compensation ranked 7,206th out of 9,135 executives tracked by ExecPay. In other words, Bagnall earned more than 21.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,206 out of 9,135 | 21st |
Division Manufacturing | 2,704 out of 3,436 | 21st |
Major group Chemicals And Allied Products | 614 out of 815 | 25th |
Industry group Drugs | 434 out of 597 | 27th |
Industry Pharmaceutical Preparations | 310 out of 408 | 24th |
Source: SEC filing on April 30, 2009.
Bagnall's colleagues
We found six more compensation records of executives who worked with Mark N.K. Bagnall at Mast Therapeutics in 2008.
2008
Evan Levine
Mast Therapeutics
Chief Executive Officer
2008
Joan Robbins
Mast Therapeutics
Chief Scientific Officer
2008
Gregory Hanson
Mast Therapeutics
Chief Financial Officer
2008
Brian Culley
Mast Therapeutics
Chief Executive Officer
2008
Patrick Keran
Mast Therapeutics
General Counsel
2008
Patrick Keran
Mast Therapeutics